<SEC-DOCUMENT>0001564590-22-008860.txt : 20220307
<SEC-HEADER>0001564590-22-008860.hdr.sgml : 20220307
<ACCEPTANCE-DATETIME>20220307074743
ACCESSION NUMBER:		0001564590-22-008860
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220307
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220307
DATE AS OF CHANGE:		20220307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TherapeuticsMD, Inc.
		CENTRAL INDEX KEY:			0000025743
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870233535
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-00100
		FILM NUMBER:		22716282

	BUSINESS ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431
		BUSINESS PHONE:		561-961-1900

	MAIL ADDRESS:	
		STREET 1:		951 YAMATO ROAD, SUITE 220
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33431

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMHN, Inc.
		DATE OF NAME CHANGE:	20090930

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF ENTERPRISES INC
		DATE OF NAME CHANGE:	19970915

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CROFF OIL CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>txmd-8k_20220307.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-07T02:40:04.3040643+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 8e2cfda6dc4a4718885cf35bbdd1fbd6 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:txmd="http://www.therapeuticsmd.com/20220307" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
txmd-8k_20220307.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000000" name="dei:AmendmentFlag" contextRef="C_0000025743_20220307_20220307">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000001" name="dei:EntityCentralIndexKey" contextRef="C_0000025743_20220307_20220307">0000025743</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="txmd-20220307.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000025743_20220307_20220307">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000025743</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2022-03-07</xbrli:startDate>
					<xbrli:endDate>2022-03-07</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;text-transform:none;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">Washington, D.C.&#160;&#160;20549</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:9pt;text-transform:uppercase;">&#160;</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:14pt;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-style:normal;font-variant: normal;">FORM <ix:nonNumeric id="F_000002" name="dei:DocumentType" contextRef="C_0000025743_20220307_20220307">8-K</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PURSUANT TO SECTION 13 OR 15(d) OF THE</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-weight:bold;text-transform:uppercase;font-size:12pt;font-family:Times New Roman;font-style:normal;font-variant: normal;">SECURITIES EXCHANGE ACT OF 1934<br /></p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:10pt;font-weight:bold;text-transform:uppercase;font-family:Times New Roman;font-style:normal;font-variant: normal;">Date of Report (Date of earliest event reported): <span style="text-transform:none;"><ix:nonNumeric id="F_000003" name="dei:DocumentPeriodEndDate" contextRef="C_0000025743_20220307_20220307" format="ixt:datemonthdayyearen">March 7, 2022</ix:nonNumeric></span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:270pt;;">
<tr>
<td style="width:270pt;"></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:22pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000004" name="dei:EntityRegistrantName" contextRef="C_0000025743_20220307_20220307">TherapeuticsMD, Inc.</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Exact Name of Registrant as Specified in its Charter)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000005" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:stateprovnameen">Nevada</ix:nonNumeric></p></td>
<td valign="top" style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000025743_20220307_20220307">001-00100</ix:nonNumeric></p></td>
<td valign="top" style="width:2%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:32%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000025743_20220307_20220307">87-0233535</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(State or Other</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Jurisdiction of Incorporation)</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td valign="top" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer<br />Identification No.)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:270pt;;">
<tr>
<td style="width:270pt;"></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityAddressAddressLine1" contextRef="C_0000025743_20220307_20220307">951 Yamato Road</ix:nonNumeric>, <ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine2" contextRef="C_0000025743_20220307_20220307">Suite 220</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressCityOrTown" contextRef="C_0000025743_20220307_20220307">Boca Raton</ix:nonNumeric>, <ix:nonNumeric id="F_000011" name="dei:EntityAddressStateOrProvince" contextRef="C_0000025743_20220307_20220307">FL</ix:nonNumeric> <ix:nonNumeric id="F_000012" name="dei:EntityAddressPostalZipCode" contextRef="C_0000025743_20220307_20220307">33431</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Office) (Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code:&#160;&#160;<span style="font-weight:bold;"><ix:nonNumeric id="F_000013" name="dei:CityAreaCode" contextRef="C_0000025743_20220307_20220307">(561)</ix:nonNumeric></span> <ix:nonNumeric id="F_000014" name="dei:LocalPhoneNumber" contextRef="C_0000025743_20220307_20220307">961-1900</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:270pt;;">
<tr>
<td style="width:270pt;"></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Not Applicable</p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000015" name="dei:WrittenCommunications" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:SolicitingMaterial" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:PreCommencementTenderOffer" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:6pt;">&#160;</p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="bottom" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td>
</tr>
</table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:40%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of Each Class</p></td>
<td valign="middle" style="width:20%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading Symbol</p></td>
<td valign="middle" style="width:40%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of Each Exchange on Which Registered</p></td>
</tr>
<tr>
<td valign="top" style="width:40%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:Security12bTitle" contextRef="C_0000025743_20220307_20220307">Common Stock, par value $0.001 per share</ix:nonNumeric></p></td>
<td valign="top" style="width:20%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:TradingSymbol" contextRef="C_0000025743_20220307_20220307">TXMD</ix:nonNumeric></p></td>
<td valign="top" style="width:40%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000; border-left:solid 0.75pt #000000; border-right:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:SecurityExchangeName" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230-405) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2). Emerging growth company <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000022" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000025743_20220307_20220307" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Times New Roman';"><span style="font-size:10pt;font-family:'Times New Roman'">&#9744;</span></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 7.01<span style="margin-left:45pt;"></span>Regulation FD Disclosure.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 7, 2022, <span style="Background-color:#FFFFFF;">TherapeuticsMD, Inc., a Nevada corporation (the &#8220;Company&#8221;),</span><span style="font-size:12pt;color:#000000;"> </span><span style="Background-color:#FFFFFF;">issued a press release announcing that it had entered into a definitive agreement to divest its vitaCare Prescription Services business to GoodRx. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:6.67%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information in this Item 7.01 and in Exhibit 99.1 attached hereto shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings.</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:9.07%;white-space:nowrap">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01</span></p></td>
<td valign="top">
<p style="margin-bottom:12pt;margin-top:0pt;font-weight:bold;color:#000000;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Financial Statements and Exhibits.</p></td></tr></table></div>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:10%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:2.41%;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)&#160;&#160;&#160;</p></td>
<td colspan="2" valign="top" style="width:10%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Exhibits</p></td>
<td colspan="2" valign="top" style="width:80%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td colspan="5" valign="top" style="width:100%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exhibit Index</span></p></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:13.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exhibit No.</span></p></td>
<td colspan="2" valign="top" style="width:84.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description </span></p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:13.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td colspan="2" valign="top" style="width:84.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:2pt;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:13.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td colspan="2" valign="top" style="width:84.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="txmd-ex991_15.htm"><span style="text-decoration:underline;">Press Release dated March 7, 2022.</span></a></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td style="border:none;padding:0;"></td>
</tr>
<tr>
<td colspan="2" valign="top" style="width:13.34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td colspan="2" valign="top" style="width:84.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document).</p></td>
<td style="border:none;padding:0;"></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:8.33%;text-indent:-8.33%;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">SIGNATURES</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:&#160;&#160;March 7, 2022</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">THERAPEUTICSMD, INC.</p></td>
</tr>
<tr>
<td valign="top" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:51%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ James C. D&#8217;Arecca</p></td>
</tr>
<tr>
<td valign="top" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">James C. D&#8217;Arecca</p></td>
</tr>
<tr>
<td valign="top" style="width:51%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:48%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Financial Officer</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>txmd-ex991_15.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
txmd-ex991_15.htm
</title>
</head>
<!-- NG Converter v5.0.2.71 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#2B579A;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk529271215"></a><img src="g4ah042igqjw000001.jpg" title="" alt="" style="width:270px;height:30px;"><font style="Background-color:#E6E6E6;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx </p>
<p style="text-align:center;margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Calibri;font-size:11pt;font-weight:normal;text-transform:none;font-variant: normal;">GoodRx has agreed to acquire vitaCare for $150 million in cash, with an additional $7 million consideration contingent upon vitaCare&#8217;s financial performance through 2023</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">BOCA RATON, Fla.--(BUSINESS WIRE)--Mar. 7, 2022<font style="font-weight:normal;">--&#160;TherapeuticsMD, Inc.&#160;(&#8220;TXMD&#8221; or the &#8220;Company&#8221;) (NASDAQ: TXMD), an innovative, leading women&#8217;s healthcare company, today announced that it has entered into a definitive agreement to divest its vitaCare Prescription Services (vitaCare) business to GoodRx (Nasdaq: GDRX), a consumer-focused digital healthcare platform. VitaCare is a technology and services platform that helps patients navigate key access and adherence barriers for brand medications. </font></p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the terms of the agreement, TXMD will receive $150 million in cash at closing, subject to customary adjustments, with up to an additional $7 million in cash consideration contingent upon vitaCare&#8217;s financial performance through 2023. The transaction is expected to close in the second quarter of 2022, subject to the satisfaction of customary closing conditions.&nbsp;&nbsp;TXMD will also enter into a long-term services agreement with vitaCare to continue to utilize the vitaCare platform.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We are pleased to find a fitting home for vitaCare and are confident that GoodRx will expand on vitaCare&#8217;s track record of increasing patient access,&#8221; said Hugh O&#8217;Dowd, Chief Executive Officer of TherapeuticsMD. &#8220;This transaction will allow TherapeuticsMD to focus on our core women&#8217;s health business and mission of empowering women of all ages through better healthcare, while at the same time delivering value for our stakeholders.&#8221;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD will further discuss this transaction and take questions on its upcoming earnings call scheduled for March 10, 2022 at 8:30 AM ET.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Advisors</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Locust Walk served as financial advisor and DLA Piper LLP (US) served as legal counsel to TherapeuticsMD.&nbsp;&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri Light;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About TherapeuticsMD, Inc.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri Light;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. TherapeuticsMD&#8217;s products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. TherapeuticsMD is committed to advancing the health of women and championing awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit <font style="text-decoration:underline;">therapeuticsmd.com</font><font style="color:#002E6D;"> </font>or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Forward-Looking Statements</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about TherapeuticsMD.&nbsp;&nbsp;Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD&#8217;s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as "believes," "hopes," "may," "anticipates," "should," "intends," "plans," "will," "expects," "estimates," "projects," "positioned," "strategy" and similar expressions and are based on assumptions and assessments made in light of management&#8217;s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">made as of the date of this press release, and TherapeuticsMD</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> control. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled "Risk Factors" in </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: whether TherapeuticsMD will be able to successfully divest</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">its </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">vitaCare</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> business and how the proceeds that may be generated by such divestiture will be utilized;</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the effects of the COVID-19 pandemic; </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ability to maintain or increase sales of its products; </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ability to develop and commercialize IMVEXXY&#174;, ANNOVERA&#174;, and BIJUVA&#174; and obtain additional financing necessary therefor; whether TherapeuticsMD</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">will be able to comply with the covenants and conditions under its term loan facility; the effects of supply chain issues on the supply of the company&#8217;s products; the potential of adverse side effects or other safety risks that could adversely affect the commercialization of </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> current or future approved products or preclude the approval of </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> future drug candidates; whether the FDA will approve the lower dose of BIJUVA and the manufacturing supplement for ANNOVERA; </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ability to protect its intellectual property, including with respect to the Paragraph IV notice letter</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the company received regarding IMVEXXY; the length, cost and uncertain results of future clinical trials; </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> reliance on third parties to conduct its manufacturing, research and development and clinical trials; the ability of </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> licensees to commercialize and distribute the company&#8217;s products; the availability of reimbursement from government authorities and health insurance companies for </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TherapeuticsMD&#8217;s</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> products; the impact of product liability lawsuits; the influence of extensive and costly government regulation; the impact of leadership transitions; </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and </font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the volatility of the trading price of the company&#8217;s common stock</font><font style="font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&nbsp;</p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">I<font style="font-weight:bold;">nvestor &amp; Media</font></p>
<p style="margin-bottom:8pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lisa M. Wilson<br />In-Site Communications, Inc.<br />T: 212-452-2793<br />E: <font style="text-decoration:underline;">lwilson@insitecony.com</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:518.25pt;;">
<tr>
<td style="width:172.75pt;"></td>
<td style="width:172.75pt;"></td>
<td style="width:172.75pt;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:-5.75pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
<td valign="top" >
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g4ah042igqjw000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g4ah042igqjw000001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q :8# 2(  A$! Q$!_\0
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ME17C&E_'?==*FJZ,$@)PTMM+DK_P$CG\Z]>L+^UU2PAOK*=)[:==\<B="/\
M/:L)TY0^)'1"K"I\++-%4-9UK3] TV34-3N5@MTXR>2Q[ #J2?05Y1=_'*YG
MNVBT;P^TL8Y!FD)<CU*J./S-.%*4]D$ZL(?$SV:BO*O#WQMT^^O%M=:L3IQ9
MMHG23?&#_M< J/?GWQ7JBLKJ&4AE(R"#P12G"4':2'"I&:O%BT5P*?$EG^(_
M_")?V2 //,7VK[1Z(6SLV_AUK.\4?&?3=(O9++2;3^TI(SMDF\S9$#Z X);]
M![FFJ,V[)$NM32NV>GT5S&G^,(&\ P>*=3C,,30^9*D"F3;\VT =^N*X&_\
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MWXL7UI;C,\\EO%&,XRS1H!^IKV[PEX)TKPEIT<5M!')>%1Y]VR_/(W?![+Z
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X!XG_Y.!M_^O\ LO\
MT&.O?Z**Z*_PQ]#EP_Q3]0HHHKG.H**** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>txmd-20220307.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-07T02:40:04.3030677+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 8e2cfda6dc4a4718885cf35bbdd1fbd6 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:txmd="http://www.therapeuticsmd.com/20220307" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.therapeuticsmd.com/20220307" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" namespace="http://xbrl.sec.gov/country/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" namespace="http://xbrl.sec.gov/currency/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" namespace="http://xbrl.sec.gov/exch/2021" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" namespace="http://xbrl.sec.gov/sic/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd" namespace="http://fasb.org/srt-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" namespace="http://fasb.org/srt-types/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd" namespace="http://fasb.org/us-roles/2021-01-31" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" namespace="http://fasb.org/us-types/2021-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.therapeuticsmd.com/20220307/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="txmd-20220307_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="txmd-20220307_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>txmd-20220307_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-07T02:40:04.3030677+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 8e2cfda6dc4a4718885cf35bbdd1fbd6 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>txmd-20220307_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2022-03-07T02:40:04.3030677+00:00 -->
<!-- Version            : 5.0.1.728 -->
<!-- Package ID         : 8e2cfda6dc4a4718885cf35bbdd1fbd6 -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.therapeuticsmd.com/20220307/role/TemplateLink" xlink:href="txmd-20220307.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="txmd-20220307.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140026032630280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000025743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  07,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TherapeuticsMD, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-00100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0233535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">951 Yamato Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boca Raton<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(561)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">961-1900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TXMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>txmd-8k_20220307_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="txmd-20220307.xsd" xlink:type="simple"/>
    <context id="C_0000025743_20220307_20220307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000025743</identifier>
        </entity>
        <period>
            <startDate>2022-03-07</startDate>
            <endDate>2022-03-07</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000025743_20220307_20220307" id="F_000000">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000025743_20220307_20220307" id="F_000001">0000025743</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0000025743_20220307_20220307" id="F_000002">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000025743_20220307_20220307" id="F_000003">2022-03-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000025743_20220307_20220307" id="F_000004">TherapeuticsMD, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000025743_20220307_20220307" id="F_000005">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000025743_20220307_20220307" id="F_000006">001-00100</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000025743_20220307_20220307" id="F_000007">87-0233535</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000025743_20220307_20220307" id="F_000008">951 Yamato Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0000025743_20220307_20220307" id="F_000009">Suite 220</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0000025743_20220307_20220307" id="F_000010">Boca Raton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0000025743_20220307_20220307" id="F_000011">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0000025743_20220307_20220307" id="F_000012">33431</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000025743_20220307_20220307" id="F_000013">(561)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000025743_20220307_20220307" id="F_000014">961-1900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000025743_20220307_20220307" id="F_000015">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000025743_20220307_20220307" id="F_000016">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000025743_20220307_20220307" id="F_000017">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000025743_20220307_20220307" id="F_000018">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000025743_20220307_20220307" id="F_000019">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000025743_20220307_20220307" id="F_000020">TXMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000025743_20220307_20220307" id="F_000021">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000025743_20220307_20220307" id="F_000022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MAVG@&L#SM5+V_<8=B\O_:DS^ 5!+ P04    " #T/6=4GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( /0]9U0<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " #T/6=4!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M /0]9U2 2H.J[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( /0]9U297)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ]#UG5&I+
M#GU*!   X1   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( /0]9U2?H!OPL0(  .(,   -
M  "  8X,  !X;"]S='EL97,N>&UL4$L! A0#%     @ ]#UG5)>*NQS
M$P(   L              ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @
M]#UG5!PX9>H_ 0  / (   \              ( !4Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( /0]9U0D'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /0]
M9U1ED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="txmd-8k_20220307.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="txmd-8k_20220307.htm">txmd-8k_20220307.htm</File>
    <File>txmd-20220307.xsd</File>
    <File>txmd-20220307_lab.xml</File>
    <File>txmd-20220307_pre.xml</File>
    <File>txmd-ex991_15.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "txmd-8k_20220307.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "txmd-8k_20220307.htm"
     ]
    },
    "labelLink": {
     "local": [
      "txmd-20220307_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "txmd-20220307_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "txmd-20220307.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "txmd",
   "nsuri": "http://www.therapeuticsmd.com/20220307",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_20220307.htm",
      "contextRef": "C_0000025743_20220307_20220307",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "txmd-8k_20220307.htm",
      "contextRef": "C_0000025743_20220307_20220307",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.therapeuticsmd.com/20220307/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-22-008860-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-22-008860-xbrl.zip
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MQC CHKSR#-E+,;UL5"B"W=>25F:6)X4MDI)*6IHSX\N-H]HRJNK*E<[-M,R
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M2S80TX&$;_=.+Y,B5E(W2]-!:F4B?>)&'JE_JDI.X?C?F\[^!U!+ P04
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M;E65(K^[S82[U*Y^=.C@CY '<<)MW01_SFD%.W2FQ*(AGC!0NQ/1;2MQ.EZ
MFD&!%UWY/V!CZ@PQ+8\=J0@CKH![%2$FZ%5W-)1C+P!VVNOM_WRM.;[5'&+=
M^+:\'_ZN3.:^L.OLS\*L>7)R"US9^)W(6N/;$E7_YT[W_*[SJ7_5[JF-\YMV
M>56>ZG65>&-QO46:MJ%"F[Q7FR_*=_N[ N^9=E2-S2_$>]\(5!$5\D^*8[3+
MY"*^E/(\8)9%=T"T-6TK?#/A6U*UG9I]J_YNJ[F=,6=#,C_0$%U:'&SG78ZM
M)4].*@//GJI9C.7$@0__#U!+ P04    " #T/6=4&(+9!V(.  ":0   $0
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MY]?BRR@D"(?1<IW\3K?_#2J)HF32"4E2IR2?3'ZM-$1=RHQNQ-\&6WV!B>2
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M",>Z*3B!Q&C[,W_<SS(Y(*1PJK9$DX>SSK6#=L>55_>@8'(N==XP@%5Z-J[
MJ$+JH#7+*=*/+8()*Y^9QKI9/*NA"U=9]I4P&#VFK+,A"MML:]ZVAX;^PCY_
MO ]KU^;)Y<)5>MFRF.05;ZC26=!K,&G')_Z9UCL/1MPP'&"TRID*KP]#!Y_
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MX@_X]WKQ7PKX'U!+ 0(4 Q0    ( /0]9U2PH7OJP 0  ((6   1
M      "  0    !T>&UD+3(P,C(P,S W+GAS9%!+ 0(4 Q0    ( /0]9U1D
M1.0%) <  %%,   5              "  >\$  !T>&UD+3(P,C(P,S W7VQA
M8BYX;6Q02P$"% ,4    " #T/6=4&;QO)AD%  "-+0  %0
M@ %&#   ='AM9"TR,#(R,#,P-U]P<F4N>&UL4$L! A0#%     @ ]#UG5#X.
M,4=T$0  XX8  !0              ( !DA$  '1X;60M.&M?,C R,C S,#<N
M:'1M4$L! A0#%     @ ]#UG5!B"V0=B#@  FD   !$              ( !
K.",  '1X;60M97@Y.3%?,34N:'1M4$L%!@     %  4 1@$  ,DQ      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
